BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28823336)

  • 1. Salvage Surgery After Definitive Chemoradiotherapy for Non-small Cell Lung Cancer.
    Casiraghi M; Maisonneuve P; Piperno G; Bellini R; Brambilla D; Petrella F; Marinis F; Spaggiari L
    Semin Thorac Cardiovasc Surg; 2017 Summer; 29(2):233-241. PubMed ID: 28823336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term outcomes beyond 5 years after pulmonary resection for non-small-cell lung cancer.
    Mizuno T; Katsumata S; Konno H; Nagata T; Isaka M; Ohde Y
    Gen Thorac Cardiovasc Surg; 2024 Jun; 72(6):401-407. PubMed ID: 38066298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: Evidence for surgery in advanced disease.
    Deboever N; Mitchell KG; Farooqi A; Ludmir EB; Hofstetter WL; Mehran RJ; Rajaram R; Rice DC; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Heymach JV; Gomez DR; Gandhi SJ; Antonoff MB
    J Thorac Cardiovasc Surg; 2024 Jun; 167(6):1929-1935.e2. PubMed ID: 37619884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Outcome after Sleeve Pneumonectomy for Thoracic Malignancy: A Comparison Between Salvage and Non-salvage.
    Imashimizu K; Suzuki K; Uchida S; Fukui M; Hattori A; Matsunaga T; Oh S; Takamochi K
    Juntendo Iji Zasshi; 2023; 69(5):388-394. PubMed ID: 38845731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoradiation for definitive, preoperative, or postoperative therapy of locally advanced non-small cell lung cancer.
    Feliciano J; Feigenberg S; Mehta M
    Cancer J; 2013; 19(3):222-30. PubMed ID: 23708069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to treatment and survival in veterans with lung cancer eligible for curative intent therapy.
    Ha D; Ries AL; Montgrain P; Vaida F; Sheinkman S; Fuster MM
    Respir Med; 2018 Aug; 141():172-179. PubMed ID: 30053964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage extended surgery after immune-checkpoint inhibitor treatment for advanced non-small cell lung cancer.
    Goto E; Hattori A; Fukui M; Matsunaga T; Takamochi K; Suzuki K
    Surg Today; 2024 Mar; ():. PubMed ID: 38517532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ALK-inhibitors in the treatment of non-small cell lung cancer: a systematic review and meta-analysis.
    Li G; Dai WR; Shao FC
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3496-3503. PubMed ID: 28829490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage Resections for Stage III Non-small Cell Lung Cancer: A Curious Area of Investigation.
    Donington JS
    Semin Thorac Cardiovasc Surg; 2017; 29(2):242-243. PubMed ID: 28823337
    [No Abstract]   [Full Text] [Related]  

  • 10. Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
    Antonia SJ; Villegas A; Daniel D; Vicente D; Murakami S; Hui R; Yokoi T; Chiappori A; Lee KH; de Wit M; Cho BC; Bourhaba M; Quantin X; Tokito T; Mekhail T; Planchard D; Kim YC; Karapetis CS; Hiret S; Ostoros G; Kubota K; Gray JE; Paz-Ares L; de Castro Carpeño J; Wadsworth C; Melillo G; Jiang H; Huang Y; Dennis PA; Özgüroğlu M;
    N Engl J Med; 2017 Nov; 377(20):1919-1929. PubMed ID: 28885881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage radiotherapy for regional lymph node oligo-recurrence after radical surgery of non-small cell lung cancer.
    Seol KH; Lee JE; Cho JY; Lee DH; Seok Y; Kang MK
    Thorac Cancer; 2017 Nov; 8(6):620-629. PubMed ID: 28906073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
    Cornwell LD; Echeverria AE; Samuelian J; Mayor J; Casal RF; Bakaeen FG; Omer S; Preventza O; Mai W; Chen G; Simpson KH; Moghanaki D; Zhu AW
    J Thorac Cardiovasc Surg; 2018 Jan; 155(1):395-402. PubMed ID: 28888379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression.
    van der Wekken AJ; Kuiper JL; Saber A; Terpstra MM; Wei J; Hiltermann TJN; Thunnissen E; Heideman DAM; Timens W; Schuuring E; Kok K; Smit EF; van den Berg A; Groen HJM
    PLoS One; 2017; 12(8):e0182885. PubMed ID: 28854272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer.
    Vellayappan BA; Soon YY; Ku GY; Leong CN; Lu JJ; Tey JC
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010511. PubMed ID: 28829911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of breathing motion and a variable relative biological effectiveness in proton therapy of left-sided breast cancer.
    Ödén J; Toma-Dasu I; Eriksson K; Flejmer AM; Dasu A
    Acta Oncol; 2017 Nov; 56(11):1428-1436. PubMed ID: 28826308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of adjuvant carboplatin-based chemotherapy compared to cisplatin in non-small cell lung cancer.
    Couillard-Montminy V; Gagnon PY; Fortin S; Côté J
    J Oncol Pharm Pract; 2019 Jan; 25(1):44-51. PubMed ID: 28825377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage thoracic surgery in patients with lung cancer: potential indications and benefits.
    Kaba E; Ozyurtkan MO; Ayalp K; Cosgun T; Alomari MR; Toker A
    J Cardiothorac Surg; 2018 Jan; 13(1):13. PubMed ID: 29357877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage surgery after definitive chemo-radiotherapy for patients with Non-Small Cell Lung Cancer.
    Romero-Vielva L; Viteri S; Moya-Horno I; Toscas JI; Maestre-Alcácer JA; Ramón Y Cajal S; Rosell R
    Lung Cancer; 2019 Jul; 133():117-122. PubMed ID: 31200817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer.
    Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
    Thorac Cardiovasc Surg; 2018 Mar; 66(2):135-141. PubMed ID: 28992654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage surgery after definitive chemoradiotherapy for patients with non-small cell lung cancer.
    Hamada A; Soh J; Mitsudomi T
    Transl Lung Cancer Res; 2021 Jan; 10(1):555-562. PubMed ID: 33569336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.